Eli Lilly Supplies the First Dual-Action GIP/GLP-1 Option
Weight Loss of Over 20% with Obesity Drug 'Mounjaro' Approved in South Korea
The obesity treatment drug 'Mounjaro' (active ingredient: tirzepatide), which has shown powerful weight loss effects exceeding 20%, has been approved in South Korea.
This medication, gaining…